Blackhawk Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-40,870
| Closed | -$2.62M | – | 73 |
|
|
2020
Q1 | $2.62M | Sell |
40,870
-586
| -1% | -$37.6K | 2.34% | 9 |
|
|
2019
Q4 | $2.1M | Buy |
41,456
+211
| +0.5% | +$10.7K | 2.09% | 13 |
|
|
2019
Q3 | $2.09M | Buy |
41,245
+1,140
| +3% | +$57.8K | 1.96% | 15 |
|
|
2019
Q2 | $1.82M | Buy |
40,105
+4,166
| +12% | +$189K | 1.74% | 21 |
|
|
2019
Q1 | $1.72M | Buy |
+35,939
| New | +$1.72M | 1.77% | 17 |
|
|
2018
Q4 | – | Sell |
-9,831
| Closed | -$453K | – | 71 |
|
|
2018
Q3 | $453K | Buy |
9,831
+8,152
| +486% | +$376K | 0.64% | 41 |
|
|
2018
Q2 | $93K | Buy |
1,679
+449
| +37% | +$24.9K | 0.11% | 122 |
|
|
2018
Q1 | $78K | Sell |
1,230
-405
| -25% | -$25.7K | 0.07% | 149 |
|
|
2017
Q4 | $100K | Buy |
+1,635
| New | +$100K | 0.09% | 121 |
|